With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.

From eRecruitment, pre-screening, eConsent, and image-based data capture, explore how a decentralized trial design helps streamline enrollment, increase patient retention, and ensure data quality.

Choosing an eCOA provider can be daunting and time consuming, while adhering to the timelines and needs of your study. Learn how an eCOA solution, backed by a DCT platform, can be a benefit to your study.

Sites are frequently overwhelmed with the sheer number of technologies they must work with to conduct a clinical trial, and this aggregation platform can streamline trial management.

Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.

Most of us rely on electronic data capture (EDC) to help us reach our study destination. How do we choose the EDC "vehicle" that will get us there safely, with minimal delays? Consider the relative importance of these key EDC features.

With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.

Discover how to enable patient- and site-centric data collection, enhance participant engagement, reduce burden, and deliver valuable real-world insights on treatment effectiveness and quality of life.

Explore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.